Imperva Given New $57.00 Price Target at Pacific Crest (IMPV)
Pacific Crest lifted their target price on shares of Imperva (NASDAQ:IMPV) from $48.00 to $57.00 in a research note issued on Monday, ARN reports. Pacific Crest’s price target would suggest a potential upside of 14.71% from the company’s current price.
Imperva (NASDAQ:IMPV) opened at 49.69 on Monday. Imperva has a 52-week low of $31.87 and a 52-week high of $52.60. The stock’s 50-day moving average is $44.18 and its 200-day moving average is $44.79. The company’s market cap is $1.240 billion.
Imperva (NASDAQ:IMPV) last released its earnings data on Tuesday, November 5th. The company reported ($0.01) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.05) by $0.04. The company had revenue of $35.10 million for the quarter, compared to the consensus estimate of $34.43 million. Imperva’s revenue was up 33.5% compared to the same quarter last year. Analysts expect that Imperva will post $-0.13 EPS for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Topeka Capital Markets initiated coverage on shares of Imperva in a research note to investors on Thursday, December 19th. They set a “hold” rating on the stock. Separately, analysts at BMO Capital Markets initiated coverage on shares of Imperva in a research note to investors on Thursday, December 19th. They set an “outperform” rating and a $52.00 price target on the stock. Finally, analysts at Barclays initiated coverage on shares of Imperva in a research note to investors on Thursday, November 21st. They set an “overweight” rating and a $55.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have given a buy rating to the stock. Imperva presently has a consensus rating of “Buy” and a consensus price target of $51.89.
In other Imperva news, CEO Shlomo Kramer sold 40,000 shares of the company’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $48.31, for a total value of $1,932,400.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Imperva, Inc is a United States-based Company that develops data security solutions for business data in the data center.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.